Sounds like Erb is stopping all trials to get the driveline less CP2 in place of CP1 but needs more time for some miniaturization , expedited approval process will get CP2 to market sooner ?
This strategy is intended to get a higher share price and faster FDA approval , hope Erb pulls it off.
So they spend almost a year getting sites back online?, page-7
Add to My Watchlist
What is My Watchlist?